2009
DOI: 10.3960/jslrt.49.117
|View full text |Cite
|
Sign up to set email alerts
|

Primary Mediastinal Non-seminomatous Germ Cell Tumor Associated with Hemophagocytic Syndrome

Abstract: A 20-year-old man with a primary non-seminomatous mediastinal germ cell tumor (yolk sac tumor and immature teratoma) developed hemophagocytic syndrome (HPS) three months after surgical resection. Around the same time, the patient was found to have bone metastases of the germ cell tumor. No other hereditary or acquired diseases related to HPS were found. The thrombocytopenia was refractory to corticosteroid therapy but improved after chemotherapy performed for germ cell tumor progression. Only three cases of ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Etoposide-based regimen has also been rarely reported to be effective in germ cell tumourrelated acquired hemophagocytic syndrome. 9 However, it is crucial that the underlying malignancy is controlled, since pharmacological or surgical tumour control is documented to provide fair pancytopenia reversal.…”
Section: Case Reportmentioning
confidence: 99%
“…Etoposide-based regimen has also been rarely reported to be effective in germ cell tumourrelated acquired hemophagocytic syndrome. 9 However, it is crucial that the underlying malignancy is controlled, since pharmacological or surgical tumour control is documented to provide fair pancytopenia reversal.…”
Section: Case Reportmentioning
confidence: 99%
“…The association between hemophagocytosis and solid tumors is anecdotal and refers almost exclusively to HLH developed in patients with mediastinal germ cell tumors [11], pediatric neuroblastoma and rhabdomyosarcoma, hepatocellular carcinoma [12], metastatic melanoma [13], squamous cell carcinoma of the neck [14], lung cancer [15], renal cell carcinoma [16], prostate cancer [17] and colon cancer [18]. …”
mentioning
confidence: 99%